Search - tctmd.com

Displaying 101 - 120 of 129

Presentation TCT 2013

Drug-eluting stent with biodegradable polymer in patients with STEMI – short and long term outcomes: data from e-NOBORI and NOBORI 2 trials

Presenter: Andres I?iguez, Farzin FATH-ORDOUBADHI, Isabel Calvo Cebollero, Albrecht Els?sser, Iskandar Atmowihardjo, Jorge Gaspar, Maciej Lesiak, Kai OPPENL?NDER, Nguyen Quang Ngoc, Ariel Roguin, Nicos Spyrou

January 31, 2013

Presentation TCT 2013

Biodegradable-Polymer Biolimus Eluting Stents Show Better Antiproliferative Efficacy And Vascular Healing Pattern Than Permanent-Polymer Paclitaxel Eluting Stents in a Preclinic...

Presenter: Armando P?rez de Prado, Claudia P?rez-Mart?nez, Alejandro Diego, Jos? Manuel Gonzalo-Orden, Carlos Cuellas, Marta Regueiro, Beatriz Mart?nez-Fern?ndez, Jose M Ajenjo, Maria J Garcia-Iglesias, Felipe Fern?ndez-V?zquez

January 31, 2013

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2012

Jason Kahn

January 02, 2013

News Conference News TCT 2012

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

November 02, 2012

Presentation TCT 2012

TCT-44. LEADERS: 5-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable...

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

TARGET I: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs an Everolimus-Eluting Stent (MicroPort)

Presenter: Run-Lin Gao

October 23, 2012

Presentation TCT 2012

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Presenter: David Kandzari

October 23, 2012

News Industry News

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

August 08, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Caitlin E. Cox

May 18, 2012

Presentation EuroPCR 2012

Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare Metal Stents in Acute Myocardial Infarction: the COMFORTABLE AMI Trial

Presenter: 168190|Lorenz Raber

May 18, 2012

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

Caitlin E. Cox

May 16, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

Presentation GI2 2012

Pathology of DES with Biodegradable Polymer: Are They Really Better?

Presenter: Renu Virmani

April 12, 2012

News Conference News ACC 2012

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

L.A. McKeown

March 26, 2012

Presentation ACC 2012

Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Presenter: Robert A. Byrne

March 24, 2012

News Daily News

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

February 21, 2012

Presentation TCT 2012

Off-Label Use of Drug Eluting Stent with Biodegradable Polymer at 2 Years.

Presenter: Gian Battista Danzi, William Wijns, Zoran Perisic, Francisco Bossa, Ren? Koning, Petr Kala, Farzin Fath-Oroubadhi, Didier Carrie, Luciano Moretti, Kai Oppenl?nder, Emanuele Barbato

January 03, 2012

Presentation TCT 2012

First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

Presenter: Bo Xu, Jie Qian, Alexandra J. Lansky, Yuejin Yang, Shubin Qiao, Yongjian Wu, Jue Chen, Fenghuan Hu, Weixian Yang, Gary S. Mintz, Martin B. Leon, Run-Lin Gao

January 03, 2012

Advertisement

Drug-eluting stent with biodegradable polymer in patients with STEMI – short and long term outcomes: data from e-NOBORI and NOBORI 2 trials

Biodegradable-Polymer Biolimus Eluting Stents Show Better Antiproliferative Efficacy And Vascular Healing Pattern Than Permanent-Polymer Paclitaxel Eluting Stents in a Preclinic...

TCTMD’s Top 10 Most Popular News Stories for 2012

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

TCT-44. LEADERS: 5-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable...

TARGET I: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs an Everolimus-Eluting Stent (MicroPort)

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare Metal Stents in Acute Myocardial Infarction: the COMFORTABLE AMI Trial

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Strong Showing for Bioabsorbable-Scaffold DES

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Pathology of DES with Biodegradable Polymer: Are They Really Better?

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

Off-Label Use of Drug Eluting Stent with Biodegradable Polymer at 2 Years.

First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content